NF-kappaB by directly targeting p65. The Journal of biological chemistry 273: 33508–33516. 55. Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, et al. (2003) A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. The Journal of biological chemistry 278: 32861–32871. 56. Kobori M, Yang Z, Gong D, Heissmeyer V, Zhu H, et al. (2004) Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell death and differentiation 11: 123–130. 57. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, et al. (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28: 1467–1472. 58. Gopalan B, Shanker M, Chada S, Ramesh R (2007) MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo. Mol Cancer 6: 11. 59. Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S, et al. (1998) The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci U S A 95: 14400–14405. 60. Wang CJ, Zhang H, Chen K, Zheng JW, Xiao CW, et al. (2010) Ad.mda-7 (IL- 24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors. Oncol Res 18: 561–574. NSAIDs and NF-kB Inhibitors in Ovarian Cancer 61. Mackenzie GG, Sun Y, Huang L, Xie G, Ouyang N, et al. (2010) Phospho- sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice. Gastroenterology 139: 1320–1332. 62. Sanyal SN, Kaur J (2010) Induction of apoptosis as a potential chemopreventive effect of dual cycloxygenase inhibitor, diclofenac, in early colon carcinogenesis. J Environ Pathol Toxicol Oncol 29: 41–53. 63. Fecker LF, Stockfleth E, Braun FK, Rodust PM, Schwarz C, et al. (2010) Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP. J Invest Dermatol 130: 2098–2109. 64. Steele VE, Rao CV, Zhang Y, Patlolla J, Boring D, et al. (2009) Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers. Cancer Prev Res (Phila Pa) 2: 951–956. 65. Lynch ED, Gu R, Pierce C, Kil J (2005) Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity. Anticancer Drugs 16: 569–579. 66. Karin M, Delhase M (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12: 85–98. 67. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB (2004) Nonsteroidal anti- inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23: 9247–9258. PLoS ONE | www.plosone.org 11 September 2011 | Volume 6 | Issue 9 | e24285